Eyenovia to participate in two upcoming investor conferences

New york, july 07, 2021 (globe newswire) -- eyenovia, inc. (nasdaq: eyen), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (map™) platform technology, today announced that management will present a corporate overview and host one-one-one meetings at the ladenburg thalmann 2021 healthcare conference, being held virtually july 13-14, 2021, and host one-on-meetings at the william blair biotech focus conference 2021, being held virtually july 14-15, 2021.
EYEN Ratings Summary
EYEN Quant Ranking